DOWNERS GROVE, Ill., Sept. 6, 2016 /CNW/ -- Univar Inc. (NYSE: UNVR) ("Univar"), a global chemical distributor and provider of value-added services, announced today it has entered into an intention agreement with Innophos Nutrition for the distribution of bioactive mineral ingredients, unique enzyme formulations, premium botanical ingredients, and specialty blends exclusively for the Canadian market effective September 15, 2016.
"We are pleased that Innophos Nutrition has put their trust in Univar for the Canadian market," said Willy St. Cyr, Univar's Vice President of Product and Industry Development and Sales Operations. "Their portfolio perfectly aligns with our strategy to expand Univar's solution set for the nutritional and natural health sectors by partnering with a world-class manufacturer dedicated to innovation, quality and applications expertise."
Bruce Brown, Vice President of Sales and Marketing at Innophos Nutrition, adds, "Innophos Nutrition continues to expand its offering of nutritional ingredients and custom solutions to regions outside of the United States. We are excited to work with Univar as our new exclusive distributor for the health and wellness market in Canada. With Univar's sales infrastructure, supply chain, and dedicated customer service, together, we are well positioned to provide customers the service they need to develop innovative products for health and wellness consumers."
Founded in 1924, Univar (NYSE: UNVR) is a global distributor of specialty and basic chemicals from more than 8,000 producers worldwide. Univar operates more than 800 distribution facilities throughout North America, Western Europe, the Asia-Pacific region, and Latin America, supported by a global network of sales and technical professionals. With a broad portfolio of products and value-added services, and deep technical and market expertise, Univar delivers the tailored solutions customers need through one of the most extensive chemical distribution networks in the world. Univar is Chemistry DeliveredSM. For more information, visit www.univar.com.
About Innophos Nutrition
Innophos Nutrition is a manufacturer and distributor of bioactive mineral ingredients, unique enzyme formulations, premium botanical ingredients, and specialty blends into the nutritional natural products industries worldwide. With multiple manufacturing facilities in the United States, it is a wholly owned subsidiary of Innophos Holdings Inc. Innophos is a leading international producer and distributor of performance-critical and nutritional specialty ingredients and blends, with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. With over 1,400 employees worldwide, Innophos combines more than a century of experience in specialty manufacturing to supply a product range produced to stringent regulatory manufacturing standards and the quality demanded by customers worldwide. For more information please visit www.innophosnutrition.com and www.innophos.com.
Forward-Looking Statements from Univar
This press release includes "forward-looking statements," including with respect to the proposed initial public offering, within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond our control. We caution you that the forward-looking information presented in this press release is not a guarantee of future events, and that actual events may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "plan," "seek," "comfortable with," "will," "expect," "intend," "estimate," "anticipate," "believe" or "continue" or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and we do not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.
Cautionary Statement from Innophos
The foregoing release includes forward-looking statements. Undue reliance on these statements should not be made. All statements other than statements of historical facts are forward-looking statements for purposes of these provisions, including, but not limited to, any projections of FDA activities, regulatory agency or other industry activities, any statements concerning products, manufacturing, licensing or other collaborative arrangements, any statements regarding future economic conditions or performance, and any statements of assumptions underlying any of the foregoing. Actual results could differ materially from those projected or assumed in the forward-looking statements. There can be no guarantee that this or any other joint venture will assist Innophos to achieve any particular levels of revenue in the future. The company's future financial condition and results of operations, as well as any forward-looking statements, are subject to inherent risks and uncertainties, including risk factors set forth in the Information Statement attached to Innophos' Form 10-K and other SEC filings. Any forward-looking statements Innophos may make today are based on assumptions that management believes to be reasonable as of this date, and Innophos undertakes no obligation to update these statements as a result of new information, future events or otherwise.
SOURCE Univar Inc.
For further information: Univar Media Relations, +1 331-777-6176, [email protected]; or Innophos Holdings, Inc., Investor Relations: (609) 366-1299, [email protected]; or FTI Consulting, Inc., Bryan Armstrong, (312) 553-6707, http://www.univar.com